Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
EndoGastric Solutions
company
About
EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
- San Mateo,California,United States
- 51 - 100
- http://www.endogastricsolutions.com
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $18M
- Industries
- Health Care,Health Diagnostics,Medical Device
- Founded date
- May 1, 2003
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- EndoGastric Solutions, Inc.
- Also Known As
- EsophyX,TIF procedure
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
22
$380.19M
EndoGastric Solutions has raised a total of
$380.19M
in funding over 2 rounds. Their latest funding was raised on
Dec 6, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 6, 2022 | Series Unknown | $18M | — | — | — | Detail |
| Nov 25, 2020 | Series Unknown | $27M | 1 |
Vertex Growth Fund
|
— | Detail |
| May 28, 2019 | Series I | $15M | 1 |
Accelmed
|
— | Detail |
| Jun 19, 2018 | Series I | $40.64M | 7 |
|
— | Detail |
| Dec 1, 2015 | Series Unknown | $50M | 6 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
6
13
EndoGastric Solutions is funded by 13 investors.
Vertex Growth Fund
and Accelmed
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Vertex Growth Fund
|
Yes | Series Unknown |
|
Accelmed
|
Yes | Series I |
|
|
Yes | Series I |
Canaan Partners
|
— | Series I |
Chicago Growth Partners
|
— | Series I |
CRG
|
— | Series I |
Evidity Health Capital
|
— | Series I |
Radius Ventures
|
— | Series I |
SightLine Partners
|
— | Series I |
Foundation Medical Partners
|
— | Series Unknown |
Employee Profiles
Number of Employee Profiles
27
EndoGastric Solutions has 27 current employee profiles, including
Board member Mike Carusi
Board member
Advisor
Advisor
Advisor
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
